Somerset Indus Fund III
Somerset Indus Fund III is a healthcare-focused India private-equity vehicle investing growth capital in accessible care, diagnostics, pharmaceuticals and medtech. Current manager and independent transaction disclosures attribute Cyrix Healthcare, Printmann Offset and NU Hospitals to Fund III.
At a glance
- Founded
- 2011
- Footprint
- Mumbai / India
- Stage
- Healthcare growth equity
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Somerset Indus Fund III uses a healthcare growth equity approach across Hospitals, diagnostics, pharmaceuticals.
Current evidence
Somerset Indus Capital Partners announced the final close of Fund III at approximately US$288 million in March 2026. Current manager materials and independent transaction reporting attribute Cyrix Healthcare, Printmann Offset and NU Hospitals to the vehicle, with NU Hospitals announced in December 2025.
Strategy
Healthcare growth equity
Sector focus
Hospitals, diagnostics, pharmaceuticals
Current signal
Somerset Indus Capital Partners announced the final close of Fund III at approximately US$288 million in March 2026. Current manager materials and independent transaction reporting attribute Cyrix Healthcare, Printmann Offset and NU Hospitals to the vehicle, with NU Hospitals announced in December 2025.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.